Advertisement

vaccine development

vaccine development

  • Rethink your Impurity Analysis Strategy

Rethink your Impurity Analysis Strategy

, , , , |

In this webinar, Dr. Ejvind Mørtz discusses the benefits and applications of mass spectrometry (MS)-based host cell protein (HCP) analysis and why HCP ELISAs are insufficient for documenting product-related impurities. Watch to learn where to apply the assay in a typical process and what you gain from deploying it to your workflow.

  • HSV Skin-on-chip FI

Skin-on-Chip for Preclinical Herpes Disease Modeling

News, Scientific Articles|

Organs-on-a-chip are attractive alternatives for bridging the translational gap between preclinical and clinical stages in vaccine development, particularly for herpes simplex virus (HSV). In this blog post, we review an article from Nature Communications on a skin-on-chip device for modeling HSV infection, as well as evaluating immune responses and antiviral drug efficacy (featured image © 2022 Sun et al., licensed under CC BY 4.0).

  • Exosome secretion from cells

Inhalable COVID-19 Vaccines: Recent Findings and Breakthroughs

News, Scientific Articles|

Given that SARS-CoV-2 is primarily transmitted through respiratory droplets, with respiratory mucosa being the main viral entry route, is intramuscular administration the most effective vaccine delivery method to fight COVID-19? In this blog post, we have reviewed one recent study that reported the design and preclinical testing of an inhalable, exosome-based COVID-19 vaccine.

Cutting Edge Conversations 2022

The Cutting Edge Conversations series offers a deep dive into specific research areas and focused insights regarding market-relevant processes from respected firms in the industry.

Go to Top